46 INTERNATIONAL PHARMACEUTICAL INDUSTRY Winter 2013 Volume 5 Issue 4 A future without antibiotics is deemed to be bleak, if bacteria continue to develop new resistance mechanisms and the pharmaceutical industry have to produce novel classes of antibiotics at the existing rate. Things may change, though. Recently, a UK-based company announced a major collaboration in the fight against resistanc...

I began to wonder about the larger question of whether there was any ethical obligation of these pharmaceutical companies to develop, produce or supply medicinal products to markets that either cannot afford them or that are too small to bring a return on the investment. After all, few would argue that a computer company has a moral obligation to develop a product for a small unprofitable marke...

Pharmaceutical funding plays an important role in medical progress. Thus, clinical and academic research has been significantly commercialized (1). There are data to suggest that economic interest from industry may have a negative influence on the objectivity of science, research publication, and even patient management (2,3). For example, a manufacturing company has been engaged “... in mislea...

Bristol-Myers Squibb is a diversified worldwide health and personal care company with principal businesses in pharmaceuticals, consumer medicines, nutritionals and medical devices. We are a leader in the research and development of innovative therapies for cardiovascular, metabolic and infectious diseases, neurological disorders, and oncology. In 2001 alone, Bristol-Myers Squibb dedicated $2.1 ...

The financial assessment of a company has been the topic debate among policy leaders as administrators, planners, economists and research workers for several years. It is method calculating effects monetary policies activities company. Financial performance review shall involve examination evaluation results in such manner to allow complete diagnostic viability soundness This study based upon 5...

funding combination is the most important issue for the companies while they know the amount of required capital. companies should be careful regarding the appliance of financial providing methods compatible with the investment strategy of company and profitability. this study seeks to examine the relationship between the capital structure and the profitability of pharmaceutical companies in ir...

Geneva Pharmaceuticals, Inc., one of the world’s largest generic drug manufacturers, is the North American hub for the Generics division of Swiss pharmaceutical and life sciences company Novartis International AG. Originally founded by Detroit pharmacist Stanley Tutag in 1946, Geneva moved its headquarters to Broomfield, Colorado in 1974. The company was subsequently acquired by Ciba Corporatio...

NEW DRUGS Rapid-Acting Clevidipine (Cleviprex) for Hypertension The U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) injectable emulsion clevidipine buty rate (Cleviprex, The Medicines Company) to reduce blood pressure when oral therapy is not feasible or desirable. A calcium-channel blocker, clevidi pine is metabolized in the blood and tissues and does not accumulate i...

Innovation is a key driver of the pharmaceutical company, from an initial discovery of a compound to the final development of a marketable and novel medicine, the web of processes to reach a viable end stage requires innovative behaviour backed by accurate knowledge. This paper analyses the use, importance and sources of knowledge within the drug development process and suggests that a pharmace...

The current shift in the marketing strategy is work by multinational pharmaceutical Companies .It is now high-end (rather than adaptive) development that is being carried out by leading companies. And, increasingly, other companies are finding themselves competing against, or working with, new innovation-based companies. My study focuses on the processes and outcomes of globally distributed pha...